Skip to main content
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.57
+1.86 (3.60%)
At close: Feb 27, 2026, 4:00 PM EST
53.68
+0.11 (0.21%)
After-hours: Feb 27, 2026, 7:59 PM EST

Moderna Revenue

In the year 2025, Moderna had annual revenue of $1.94B, down -39.93%. Moderna had revenue of $678.00M in the quarter ending December 31, 2025, a decrease of -29.81%.

Revenue (ttm)
$1.94B
Revenue Growth
-39.93%
P/S Ratio
10.88
Revenue / Employee
$413,617
Employees
4,700
Market Cap
21.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.94B-1.29B-39.93%
Dec 31, 20243.24B-3.61B-52.75%
Dec 31, 20236.85B-12.42B-64.45%
Dec 31, 202219.26B792.00M4.29%
Dec 31, 202118.47B17.67B2,200.25%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Incyte 5.14B
Genmab 3.72B
BioNTech SE 3.70B
Royalty Pharma 2.38B
Ionis Pharmaceuticals 944.00M
Ascendis Pharma 845.52M
Insmed 606.42M
BridgeBio Pharma 502.08M
Revenue Rankings

MRNA News

More News